Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/2724
Title: Radiotracer studies of the antitumor metallocene molybdocene dichloride with biomolecules
Authors: Campbell, KS
Dillon, CT
Smith, SV
Harding, MM
Keywords: Irradiation
Radiopharmaceuticals
Tracer techniques
Thin-layer chromatography
Spectroscopy
Blood serum
Issue Date: 22-Jan-2007
Publisher: Elsevier
Citation: Campbell, K. S., Dillon, C. T., Smith, S. V., & Harding, M. M. (2007). Radiotracer studies of the antitumor metallocene molybdocene dichloride with biomolecules. Polyhedron, 26(2), 456-459. doi:10.1016/j.poly.2006.07.004
Abstract: Neutron irradiation of Cp2MoCl2 for 24 h afforded the radiotracer Cp299MoCl2 which was characterised by UV–Vis spectroscopy and thin layer chromatography. Binding experiments with the thiol containing protein human serum albumin (HSA) or calf thymus DNA, were monitored for 99Mo using a gamma counter. Under the conditions investigated, molar ratios of binding of 0.2:1 (Cp2MoCl2:DNA) and 9.4:1 (Cp2MoCl2:HSA) were calculated. The results are consistent with in vitro coordination studies that have shown strong preferential interaction of Cp2MoCl2 with thiols versus other donor sites in biomolecules including DNA. © 2007, Elsevier Ltd.
Gov't Doc #: 2885
URI: http://dx.doi.org/10.1016/j.poly.2006.07.004
http://apo.ansto.gov.au/dspace/handle/10238/2724
ISSN: 0277-5387
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.